Regulatory & Legal

The punk band will hold a free acoustic show honoring Alex Pretti and Renée Good, raising funds for a community reeling from tragedy and federal action.

A leading bar association challenges the 'cost center' view, arguing New York's courts are a key driver of economic growth and tax revenue.

A new state-backed decal helps consumers spot legal cannabis sellers. Discover how the 'Verified Dispensary' program aims to ensure safety and combat illicit sales.

As Lachlan Murdoch prepares to address industry leaders, all eyes are on Fox's strategy for streaming, sports rights, and navigating a shifting media world.

Peter S. Thompson's leadership on the RetirePath program is gaining national praise, providing a blueprint for how states can tackle the retirement crisis.

Solana Company is building a massive infrastructure in Asia, but can this bold, high-risk play conquer the complex regulatory landscape and win the race?

Agile Defense has won a coveted phase one spot on the Alliant 3 contract, positioning it to deliver AI and cyber solutions to the U.S. government.

With a massively oversubscribed bond offering, Canada's leading alternative lender signals its rapid ascent into the financial mainstream. Here's what it means.

With the launch of Steelforce America, the global steel firm appoints a new CEO to capture growth in a dynamic, multi-billion dollar market.

With a record 8 million kg of batteries collected in 2025, Canada is winning its fight against waste. See how local efforts are paving the way for an EV future.

With its stock under pressure, Geron will face investors to defend its RYTELO sales strategy and address delays in its pivotal myelofibrosis trial.

Outdoor Holding Co. ends a major legal distraction with a $4.4M payment, allowing it to fully focus on innovating its GunBroker.com marketplace.

BioVie faces a pivotal moment, touting breakthrough drugs for Alzheimer's and cirrhosis while navigating clinical setbacks and financial pressures.

OptimumBank Holdings leverages its deep expertise in healthcare and multifamily real estate by launching OptimumFunding, a new HUD and FHA lending platform.

Verrica Pharmaceuticals heads to a key investor conference with strong YCANTH sales, a promising pipeline for warts and skin cancer, and high expectations.

A brief delay in Avidity's stockholder vote signals the final, complex steps before its acquisition by Novartis and the launch of a new spin-off.

After halting all R&D, PCI Biotech proposes dissolution and delisting, marking the end for its novel drug delivery platform and a warning for investors.

Madison Capital Group offers a new DST for a luxury Asheville community, tapping a hot market facing a surge in supply and evolving economic crosscurrents.

Following a series of acquisitions, Southwest Strategies Group rebrands as Bodewell, positioning itself to manage public consent for a new era of US infrastructure.

With stellar trial data and a fast-tracked FDA submission, CG Oncology prepares for a pivotal presentation at the TD Cowen Health Care Conference.